ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 199 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $84,000 | -12.5% | 1,000 | 0.0% | 0.01% | -14.3% |
| Q1 2019 | $96,000 | +35.2% | 1,000 | 0.0% | 0.01% | +16.7% |
| Q4 2018 | $71,000 | -16.5% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $85,000 | -26.7% | 1,000 | 0.0% | 0.01% | -33.3% |
| Q2 2018 | $116,000 | +43.2% | 1,000 | 0.0% | 0.02% | +38.5% |
| Q1 2018 | $81,000 | +37.3% | 1,000 | 0.0% | 0.01% | +44.4% |
| Q4 2017 | $59,000 | +25.5% | 1,000 | 0.0% | 0.01% | +12.5% |
| Q3 2017 | $47,000 | +30.6% | 1,000 | 0.0% | 0.01% | +33.3% |
| Q2 2017 | $36,000 | +16.1% | 1,000 | 0.0% | 0.01% | +20.0% |
| Q1 2017 | $31,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |